CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE cream United States - English - NLM (National Library of Medicine)

clotrimazole and betamethasone dipropionate cream

nucare pharmaceuticals,inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole and betamethasone dipropionate cream is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum , trichophyton mentagrophytes , and trichophyton rubrum in patients 17 years and older. none. risk summary there are no available data on topical betamethasone dipropionate or clotrimazole use in pregnant women to identify a clotrimazole and betamethasone dipropionate cream associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. observational studies suggest an increased risk of low birthweight infants with the use of potent or very potent topical corticosteroid during pregnancy. advise pregnant women that clotrimazole and betamethasone dipropionate cream may increase the risk of having a low birthweight infant and to use clotrimazole and betamethasone dipropionate cream on the sma

CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE cream United States - English - NLM (National Library of Medicine)

clotrimazole and betamethasone dipropionate cream

bryant ranch prepack - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole and betamethasone dipropionate cream is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum, trichophyton mentagrophytes, and trichophyton rubrum in patients 17 years and older. none. risk summary there are no available data on topical betamethasone dipropionate or clotrimazole use in pregnant women to identify a clotrimazole and betamethasone dipropionate cream associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. observational studies suggest an increased risk of low birthweight infants with the use of potent or very potent topical corticosteroid during pregnancy. advise pregnant women that clotrimazole and betamethasone dipropionate cream may increase the risk of having a low birthweight infant and to use clotrimazole and betamethasone dipropionate cream on the smallest area of skin and for the shortest

CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE cream United States - English - NLM (National Library of Medicine)

clotrimazole and betamethasone dipropionate cream

preferred pharmaceuticals inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole and betamethasone dipropionate cream is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum, trichophyton mentagrophytes, and trichophyton rubrum in patients 17 years and older. none. risk summary there are no available data on topical betamethasone dipropionate or clotrimazole use in pregnant women to identify a clotrimazole and betamethasone dipropionate cream associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. observational studies suggest an increased risk of low birthweight infants with the use of potent or very potent topical corticosteroid during pregnancy. advise pregnant women that clotrimazole and betamethasone dipropionate cream may increase the risk of having a low birthweight infant and to use clotrimazole and betamethasone dipropionate cream on the smallest area of skin and for the shortest

CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE cream United States - English - NLM (National Library of Medicine)

clotrimazole and betamethasone dipropionate cream

preferred pharmaceuticals inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole and betamethasone dipropionate cream is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum , trichophyton mentagrophytes , and trichophyton rubrum in patients 17 years and older. none. risk summary there are no available data on topical betamethasone dipropionate or clotrimazole use in pregnant women to identify a clotrimazole and betamethasone dipropionate cream associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. observational studies suggest an increased risk of low birthweight infants with the use of potent or very potent topical corticosteroid during pregnancy. advise pregnant women that clotrimazole and betamethasone dipropionate cream may increase the risk of having a low birthweight infant and to use clotrimazole and betamethasone dipropionate cream on the smallest area of skin and for the shortest

CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE cream United States - English - NLM (National Library of Medicine)

clotrimazole and betamethasone dipropionate cream

advanced rx pharmacy of tennessee, llc - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole and betamethasone dipropionate cream is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum , trichophyton mentagrophytes , and trichophyton rubrum in patients 17 years and older. none. risk summary there are no available data on topical betamethasone dipropionate or clotrimazole use in pregnant women to identify a clotrimazole and betamethasone dipropionate cream associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. observational studies suggest an increased risk of low birthweight infants with the use of potent or very potent topical corticosteroid during pregnancy. advise pregnant women that clotrimazole and betamethasone dipropionate cream may increase the risk of having a low birthweight infant and to use clotrimazole and betamethasone dipropionate cream on the smallest area of skin and for the

Canesten Clotrimazole Thrush 1 Day Cream New Zealand - English - Medsafe (Medicines Safety Authority)

canesten clotrimazole thrush 1 day cream

bayer new zealand limited - clotrimazole 10%{relative} (micronised ) - vaginal cream - 10 % - active: clotrimazole 10%{relative} (micronised ) excipient: benzyl alcohol cetostearyl alcohol cetyl palmitate isopropyl myristate polysorbate 60 purified water sorbitan stearate - canesten clotrimazole thrush treatment once, 3 day and 6 day creams are indicated for the topical treatment of vulvovaginal candidiasis. canesten clotrimazole cream may also be used in conjunction with canesten clotrimazole vaginal pessaries in the management of candida vulvovaginitis or infection of the peri-anal area, while application of the cream to the glans penis of the partner may help prevent re-infection of the female.

Canesten Clotrimazole Thrush 1 Day Pessary New Zealand - English - Medsafe (Medicines Safety Authority)

canesten clotrimazole thrush 1 day pessary

bayer new zealand limited - clotrimazole 500mg (micronised) - pessary - 500 mg - active: clotrimazole 500mg (micronised) excipient: calcium lactate, hydrate as pentahydrate colloidal silicon dioxide crospovidone hypromellose lactic acid lactose monohydrate magnesium stearate maize starch microcrystalline cellulose - canesten clotrimazole thrush 1 day pessary and 6 day vaginal pessaries are indicated for the topical treatment of vaginal candidiasis.

Canesten Clotrimazole Thrush 1 Day Pessary & Cream New Zealand - English - Medsafe (Medicines Safety Authority)

canesten clotrimazole thrush 1 day pessary & cream

bayer new zealand limited - clotrimazole 500mg (micronised); clotrimazole 1%; clotrimazole 1%{relative} - combination - active: clotrimazole 500mg (micronised) excipient: calcium lactate, hydrate as pentahydrate colloidal silicon dioxide crospovidone hypromellose lactic acid lactose monohydrate magnesium stearate maize starch microcrystalline cellulose active: clotrimazole 1% excipient: benzyl alcohol cetostearyl alcohol cetyl palmitate octyldodecanol polysorbate 60 purified water sorbitan stearate active: clotrimazole 1%{relative} excipient: benzyl alcohol cetostearyl alcohol cetyl palmitate octyldodecanol polysorbate 60 purified water sorbitan stearate - canestan clotrimazole thrush 1 day pessary & cream is indicated for the topical treatment of vulvovaginal candidiasis. the cream can also be used in the management of candida vulvovaginitis or infection of the peri-anal area, while application of the cream to the glans penis of the partner may help prevent re-infection of the female.

Canesten Clotrimazole Thrush 3 Day Cream New Zealand - English - Medsafe (Medicines Safety Authority)

canesten clotrimazole thrush 3 day cream

bayer new zealand limited - clotrimazole 2%{relative}; clotrimazole 2%{relative} - vaginal cream - 2 % - active: clotrimazole 2%{relative} excipient: benzyl alcohol cetostearyl alcohol cetyl palmitate octyldodecanol polysorbate 60 purified water sorbitan stearate active: clotrimazole 2%{relative} excipient: benzyl alcohol cetostearyl alcohol cetyl palmitate octyldodecanol polysorbate 60 purified water sorbitan stearate - canesten clotrimazole thrush treatment once, 3 day and 6 day creams are indicated for the topical treatment of vulvovaginal candidiasis. canesten clotrimazole cream may also be used in conjunction with canesten clotrimazole vaginal pessaries in the management of candida vulvovaginitis or infection of the peri-anal area, while application of the cream to the glans penis of the partner may help prevent re-infection of the female.

Canesten Clotrimazole Thrush 6 Day Cream New Zealand - English - Medsafe (Medicines Safety Authority)

canesten clotrimazole thrush 6 day cream

bayer new zealand limited - clotrimazole 1%{relative}; clotrimazole 1%{relative} - vaginal cream - 1 % - active: clotrimazole 1%{relative} excipient: benzyl alcohol cetostearyl alcohol cetyl palmitate octyldodecanol polysorbate 60 purified water sorbitan stearate active: clotrimazole 1%{relative} excipient: benzyl alcohol cetostearyl alcohol cetyl palmitate octyldodecanol polysorbate 60 purified water sorbitan stearate - canesten clotrimazole thrush treatment once, 3 day and 6 day creams are indicated for the topical treatment of vulvovaginal candidiasis. canesten clotrimazole cream may also be used in conjunction with canesten clotrimazole vaginal pessaries in the management of candida vulvovaginitis or infection of the peri-anal area, while application of the cream to the glans penis of the partner may help prevent re-infection of the female.